Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rocco

Showing results (611-620 of 621) with videos related to

Pageof 63
Sort By:
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 9, 2020
Differential effects of the cystic fibrosis lung inflammatory environment on mesenchymal stromal cellsSoraia C Abreu, Thomas H Hampton, Evan Hoffman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2023
Preventing occludin tight-junction disruption via inhibition of microRNA-193b-5p attenuates viral load and influenza-induced lung injuryChirag M Vaswani, Amir K Varkouhi, Sahil Gupta, et al.
Cytotherapy|December 20, 2025
Fate and function of exogenously administered mesenchymal stromal cells: current insights and future directionsAli Shokoohmand, Nikita M Patel, Lorena Braid, et al.
Lancet (London, England)|July 21, 2001
Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two casesP F Vasconcelos, E J Luna, R Galler, et al.
Journal of Clinical Medicine|July 2, 2021
Tracheostomy Timing and Outcome in Severe COVID-19: The WeanTrach Multicenter StudyDenise Battaglini, Francesco Missale, Irene Schiavetti, et al.
The European Respiratory Journal|December 28, 2020
Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trialPatricia R M Rocco, Pedro L Silva, Fernanda F Cruz, et al.
Kidney International|July 22, 2011
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal TrialMichael V Rocco, Robert S Lockridge, Gerald J Beck, et al.
Plos Pathogens|August 9, 2020
Genomic Surveillance of Yellow Fever Virus Epizootic in São Paulo, Brazil, 2016 - 2018Sarah C Hill, Renato de Souza, Julien Thézé, et al.
Frontiers in Medicine|May 2, 2022
Nitazoxanide in Patients Hospitalized With COVID-19 Pneumonia: A Multicentre, Randomized, Double-Blind, Placebo-Controlled TrialPatricia R M Rocco, Pedro L Silva, Fernanda F Cruz, et al.
Blood|December 10, 2025
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosisJoseph M Rocco, Joseph H Oved, Rikita J Patel, et al.
Pageof 63

Showing results (611-620 of 621) with videos related to

Sort By:
Pageof 63
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 9, 2020
Differential effects of the cystic fibrosis lung inflammatory environment on mesenchymal stromal cellsSoraia C Abreu, Thomas H Hampton, Evan Hoffman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2023
Preventing occludin tight-junction disruption via inhibition of microRNA-193b-5p attenuates viral load and influenza-induced lung injuryChirag M Vaswani, Amir K Varkouhi, Sahil Gupta, et al.
Cytotherapy|December 20, 2025
Fate and function of exogenously administered mesenchymal stromal cells: current insights and future directionsAli Shokoohmand, Nikita M Patel, Lorena Braid, et al.
Lancet (London, England)|July 21, 2001
Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two casesP F Vasconcelos, E J Luna, R Galler, et al.
Journal of Clinical Medicine|July 2, 2021
Tracheostomy Timing and Outcome in Severe COVID-19: The WeanTrach Multicenter StudyDenise Battaglini, Francesco Missale, Irene Schiavetti, et al.
The European Respiratory Journal|December 28, 2020
Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trialPatricia R M Rocco, Pedro L Silva, Fernanda F Cruz, et al.
Kidney International|July 22, 2011
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal TrialMichael V Rocco, Robert S Lockridge, Gerald J Beck, et al.
Plos Pathogens|August 9, 2020
Genomic Surveillance of Yellow Fever Virus Epizootic in São Paulo, Brazil, 2016 - 2018Sarah C Hill, Renato de Souza, Julien Thézé, et al.
Frontiers in Medicine|May 2, 2022
Nitazoxanide in Patients Hospitalized With COVID-19 Pneumonia: A Multicentre, Randomized, Double-Blind, Placebo-Controlled TrialPatricia R M Rocco, Pedro L Silva, Fernanda F Cruz, et al.
Blood|December 10, 2025
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosisJoseph M Rocco, Joseph H Oved, Rikita J Patel, et al.
Pageof 63